Abstract
The aging of family caregivers and the challenges of long-distance caregiving attributed to the increase in the number of elderly individuals living alone have raised concerns about dementia caregiving in Japan. Additionally, with the shifts in family dynamics due to declining birth rates and an extended average lifespan, adapting support strategies for family caregivers is necessary. Thus, it is necessary to measure the caregiving competence of family caregivers early and effectively. However, a comprehensive caregiving competence scale tailored to dementia, including aspects such as caregiving burden, affirmation, and coping, is lacking. Therefore, this study aimed to develop a Caregiving Competence Scale for Dementia (CCSD) for primary family caregivers caring for individuals with dementia. This study focused on primary family caregivers caring for individuals with cognitive impairment and various degrees of dementia. The initial version of the CCSD was developed, and a questionnaire survey was conducted to validate its structural validity and reliability. A total of 150 participants were included in the analysis. The exploratory factor analysis identified five factors with 27 items: Factor 1: “Positive Emotions and Awareness,” Factor 2: “Presence or Absence of Consultation Partners and Family Support,” Factor 3: “Caregiving Burden and Coping Skills,” Factor 4: “Dementia Literacy,” and Factor 5: “Engagement and Emotional Control.” The confirmatory factor analysis revealed a good model fit (comparative fit index = 0.905 and root mean square error of approximation = 0.072). The overall Cronbach’s alpha coefficient for the scale was 0.892. The CCSD, comprising 27 items covering five factors, has been successfully developed as a measurement scale. Measuring caregiving competence contributes to developing targeted support strategies for primary family caregivers and facilitating appropriate interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Kyoto Tachibana University Research Ethics 181 Committee (Approval Number: 22-60, Approval Date: March 23, 2023).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
